Ocularis Pharma


  • Alan R. Meyer


    Founder and Chief Executive Officer of Ocularis. Mr. Meyer was Executive Vice President and Chief Financial Officer of PathoGenesis and has more than 30 years of experience in operations, finance and business development in the healthcare products industry, including eight years at PathoGenesis and six years at Baxter International.
  • William H. Pitlick, Ph.D.


    Founder and Chief Development Officer of Ocularis. Dr. Pitlick was Vice President of Regulatory Affairs for Chiron and Vice President Regulatory Affairs and Clinical Development for PathoGenesis. Dr. Pitlick has over 30 years of experience in pharmaceutical clinical development and regulatory affairs, including the FDA, the National Institutes of Health and Otsuka Pharmaceutical Co.
  • Bernhard (Charlie) Hoffmann


    Consultant to Ocularis for Business Development. Mr. Hoffmann has over 25 years of experience in the investment banking industry, much of it focused on the life sciences industry, including Prudential Vector Healthcare, First Boston, and Goldman Sachs.